Literature DB >> 30350892

Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: A single-center experience in a multidisciplinary team.

Marie-Aimée Perrouin-Verbe1, Priscilla Léon1, Pierre Denys2, Pierre Mongiat-Artus3, Emmanuel Chartier-Kastler1, Véronique Phé1.   

Abstract

AIM: To report the very long-term functional outcomes of augmentation cystoplasty (AC) in adult spina bifida patients.
METHODS: All consecutive adult spina bifida patients who underwent AC between 1991 and 2008 were enrolled. Early postoperative complications (Clavien-Dindo classification) and long-term outcomes (voiding modalities, urodynamic parameters, renal function, continence, and quality of life) were assessed.
RESULTS: Twenty-eight patients with a median age of 20 years (IQR 17-25) were included. They all underwent AC with a supratrigonal cystectomy (SC). The median follow-up was 13.6 years (IQR 6-16.5). Thirteen early postoperative complications (12 grade I-II, 1 grade III) were observed in 11 patients (39%). Eight patients (29%) had upper urinary tract infections managed with antibiotics, with 2 patients requiring ureteral stents. Bladder stones occurred in 2 patients (7%) and were managed with endoscopy and cystostomy. One bladder perforation was reported. One bladder cancer was observed 26 years after surgery. Creatinine clearance and all urodynamic parameters were significantly improved post-operatively. The overall complication and reoperation rates were 57% and 14%, respectively. At last follow up, the continence rate was 71% (n = 20), with 93% (n = 26) performing intermittent self-catheterization. Quality of life was improved for 71% of patients.
CONCLUSION: In adult spina bifida population, AC is a high-risk procedure with an overall complication rate of 57% and a reoperation rate of 14%. However, AC is beneficial to the overall health of the patients since it provides a satisfying continence rate, an improvement of quality of life, and long-term protection of the upper urinary tract.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  augmentation cystoplasty; enterocystoplasty; kidney function; neurogenic bladder; neurogenic detrusor overactivity; quality of life; spina bifida; supratrigonal cystectomy

Mesh:

Year:  2018        PMID: 30350892     DOI: 10.1002/nau.23857

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  6 in total

Review 1.  Augmentation cystoplasty in the patient with neurogenic bladder.

Authors:  Philip J Cheng; Jeremy B Myers
Journal:  World J Urol       Date:  2019-09-11       Impact factor: 4.226

2.  Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury.

Authors:  A Balanca; A Even; C Malot; E Chartier-Kastler; P Denys; C Joussain
Journal:  World J Urol       Date:  2022-06-10       Impact factor: 3.661

Review 3.  Outcomes of pregnancy and delivery in women with continent lower urinary tract reconstruction: systematic review of the literature.

Authors:  Elsa Bey; Brigitte Perrouin-Verbe; Bénédicte Reiss; Marc Lefort; Loïc Le Normand; Marie Aimée Perrouin-Verbe
Journal:  Int Urogynecol J       Date:  2021-06-14       Impact factor: 2.894

Review 4.  Contemporary management considerations of urinary tract infections for women with spina bifida.

Authors:  Ellen Fremion; Paola Bustillos; Rose Khavari
Journal:  Int Urogynecol J       Date:  2021-06-03       Impact factor: 2.894

5.  Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder.

Authors:  Sanjay Sinha; Mehul Shah
Journal:  Asian J Urol       Date:  2021-06-01

6.  Cognitive challenges in persons with spina bifida: Bearing on urological dysfunctions?

Authors:  Ingrid Ehrén; Göran Hagman; Lena Lindbo; Hanna Gabrielsson; Martina Bendt; Åke Seiger
Journal:  Neurourol Urodyn       Date:  2020-09-22       Impact factor: 2.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.